Diabetes Archives - MDNewsline

Diabetes

Q & A with Danielle Bublitz, MS, RD, on Diabetes

Danielle Bublitz, MS, RD is a registered dietitian and certified intuitive eating counselor. She created her own online company in November 2021 called Food Freedom Diabetes, LLC to assist people with diabetes, and she also…

Daysha RobinsonOctober 31, 2022

Diabetes Health Care Reform

Decreased Use of New Medications in Minority Populations with Diabetes

Research suggests that minorities are less likely to be prescribed newer diabetes medications than their White counterparts of similar socioeconomic status and diabetes management. As of 2021, the United States Food and Drug Administration (FDA)…

Daysha RobinsonOctober 25, 2022

Black patient with doctor in doctors office

Diabetes Health Disparities

Clinical Diabetes Trials and Minority Underrepresentation

Minority underrepresentation in clinical trials can adversely affect patient outcomes in minority populations and further increase racial disparities. Racial disparities in clinical trials adversely affect patient outcomes in minority populations. Although historically, Black populations have…

Daysha RobinsonOctober 25, 2022

Diabetes Health Disparities

Early Identification of Diabetes in Minority Populations

Research shows that Asian, Hispanic, and Black Americans are at increased risk for diabetes at lower weights and younger ages than White Americans. Adult-onset diabetes is one of the most common chronic conditions in adults…

Daysha RobinsonOctober 25, 2022

Diabetes Obesity

The Role of Obesity and Diabetes in Dementia

The underlying pathological mechanisms of obesity overlap with those of dementia and diabetes mellitus. Age, gender, Western diet, depression, and genetic and epigenetic factors mediate an inflammatory state, which leads to metabolic dysregulation. The development…

Daysha RobinsonOctober 19, 2022

Diabetes

Ipragliflozin in Diabetes Patients with NAFLD

SGLT-2is, including ipragliflozin, are an effective therapeutic modality for diabetes patients with NAFLD. Ipragliflozin is also effective in the resolution of NASH and in mediating obesity and glycemic control. Sodium–glucose co-transporter 2 inhibitors (SGLT-2is) are…

Daysha RobinsonOctober 19, 2022

Dentistry and Oral Health Diabetes

Diabetes Mellitus and Dental Implants

This systematic review discussed the complications of dental implant procedures in diabetes mellitus and pre-diabetes patients. Implementation and adherence to preventive anti-infective measures under controlled glycemic conditions effectively reduces dental implant surgery complications in patients…

Daysha RobinsonOctober 19, 2022

Diabetes

Proton Pump Inhibitors and Risk of Type 2 Diabetes Mellitus

Long-term and regular use of PPIs in treating acid-related diseases can lead to the onset of T2DM, particularly in younger patients with higher clinical severity, according to a recent case-control study. Therefore, physicians are advised…

Daysha RobinsonOctober 19, 2022

Diabetes

Type 2 Diabetes Mellitus and Antibiotic Resistant Infections

Patients with T2DM are more likely to experience resistant infections, mainly of the respiratory and urinary tracts, than healthy individuals, according to a recent meta-review. Type 2 diabetes mellitus (T2DM) is a global health burden…

Daysha RobinsonOctober 19, 2022

Diabetes

Sleep Disorders and the Development of Type 2 Diabetes Mellitus

A recent review article explored the effects of sleep behaviors and disorders on the progression of pre-diabetes to type 2 DM and found positive associations with insomnia, night shift duty, and short sleep duration. Certain…

Daysha RobinsonOctober 13, 2022

1 2 3 … 37 Next

Diabetes

Q & A with Danielle Bublitz, MS, RD, on Diabetes

Decreased Use of New Medications in Minority Populations with Diabetes

Clinical Diabetes Trials and Minority Underrepresentation

Early Identification of Diabetes in Minority Populations

The Role of Obesity and Diabetes in Dementia

Ipragliflozin in Diabetes Patients with NAFLD

Diabetes Mellitus and Dental Implants

Proton Pump Inhibitors and Risk of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus and Antibiotic Resistant Infections

Sleep Disorders and the Development of Type 2 Diabetes Mellitus

Categories

What’s New

Follow Us

Subscribe To Our Newsletter

About Us

Resources

Support